These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11206720)

  • 1. Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy.
    Watanabe K; Ohta Y; Kouda T; Sekiguchi T; Sato S; Nakazawa M; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S49-54. PubMed ID: 11206720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term treatment with nonselective endothelin receptor antagonist, TAK-044, on remodeling of cardiovascular system with sustained volume overload.
    Tojo T; Tsunoda Y; Nakada S; Tomoike H
    J Cardiovasc Pharmacol; 2000 May; 35(5):777-85. PubMed ID: 10813381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.
    Plumpton C; Ferro CJ; Haynes WG; Webb DJ; Davenport AP
    Br J Pharmacol; 1996 Sep; 119(2):311-4. PubMed ID: 8886414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal haemodynamic effects of endothelin-1 and the ETA/ETB antagonist TAK-044 in anaesthetized rabbits.
    Evans RG; Bergström G; Cotterill E; Anderson WP
    J Hypertens; 1998 Dec; 16(12 Pt 2):1897-905. PubMed ID: 9886875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and biochemical effects of endothelin-A- and -B-receptor antagonist TAK-044 in stroke-prone spontaneously hypertensive rats.
    Naruse M; Tanabe A; Naruse K; Adachi C; Yoshimoto T; Seki T; Takagi S; Imaki T; Watanabe T; Takano K
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S334-6. PubMed ID: 11078413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
    Cirino M; Martin E; Yano M; Rodger IW
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
    Ferro CJ; Haynes WG; Johnston NR; Lomax CC; Newby DE; Webb DJ
    Br J Clin Pharmacol; 1997 Oct; 44(4):377-83. PubMed ID: 9354313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonselective endothelin receptor antagonist initiated soon after the onset of myocardial infarction may deteriorate 24-hour survival.
    Takahashi C; Kagaya Y; Namiuchi S; Takeda M; Fukuchi M; Otani H; Ninomiya M; Yamane Y; Kohzuki M; Watanabe J; Shirato K
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):29-38. PubMed ID: 11444500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the ET(A)/ET(B) antagonist, TAK-044, on blood pressure and renal excretory function after unclipping of conscious one-kidney-one-clip hypertensive rats.
    Bergström G; Nyström HC; Jia J; Evans RG
    J Hypertens; 2001 Mar; 19(3 Pt 2):659-65. PubMed ID: 11327643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.
    Fleisch M; Sütsch G; Yan XW; Wenzel RR; Binggeli C; Bianchetti MG; Meier B; Kiowski W; Lüscher TF
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):302-9. PubMed ID: 10975586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ET(A) and ET(B) receptors in endothelin-1-induced adrenal catecholamine secretion in vivo.
    Yamaguchi N
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1290-7. PubMed ID: 9140032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model.
    Szabó G; Fazekas L; Bährle S; MacDonald D; Stumpf N; Vahl CF; Hagl S
    Cardiovasc Res; 1998 Sep; 39(3):683-90. PubMed ID: 9861312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart.
    Kusumoto K; Fujiwara A; Ikeda S; Watanabe T; Fujino M
    Eur J Pharmacol; 1996 Jan; 296(1):65-74. PubMed ID: 8720478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
    Mickley EJ; Gray GA; Webb DJ
    Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy.
    Suzuki M; Ohte N; Wang ZM; Williams DL; Little WC; Cheng CP
    Cardiovasc Res; 1998 Sep; 39(3):589-99. PubMed ID: 9861301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative chronotropic and inotropic effects of endothelin isopeptides in mammalian cardiac muscle.
    Zhu Y; Yang HT; Endoh M
    Am J Physiol; 1997 Jul; 273(1 Pt 2):H119-27. PubMed ID: 9249482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.
    Haynes WG; Ferro CJ; O'Kane KP; Somerville D; Lomax CC; Webb DJ
    Circulation; 1996 May; 93(10):1860-70. PubMed ID: 8635265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated vascular and metabolic actions of endothelin-1 in canine small intestine.
    King-VanVlack CE; Mewburn JD; Chapler CK
    Am J Physiol; 1999 May; 276(5):G1131-6. PubMed ID: 10330003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated reversal of carbon tetrachloride-induced cirrhosis in rats by the endothelin receptor antagonist TAK-044.
    Anselmi K; Subbotin VM; Nemoto E; Gandhi CR
    J Gastroenterol Hepatol; 2002 May; 17(5):589-97. PubMed ID: 12084034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.